H-series protein kinase inhibitors and potential clinical applications.
about
Prostacyclin-dependent apoptosis mediated by PPAR deltaMetabolic actions of Rho-kinase in periphery and brainAnomalous dispersion analysis of inhibitor flexibility: a case study of the kinase inhibitor H-89De Novo Fragment Design for Drug Discovery and Chemical BiologyConservation, variability and the modeling of active protein kinasesPhos-tag-based analysis of myosin regulatory light chain phosphorylation in human uterine myocytes(D)-Amino acid analogues of DT-2 as highly selective and superior inhibitors of cGMP-dependent protein kinase Ialpha.Fasudil, a Clinically Used ROCK Inhibitor, Stabilizes Rod Photoreceptor Synapses after Retinal DetachmentEffects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits.A phosphoprotein from the archaeon Sulfolobus solfataricus with protein-serine/threonine kinase activity.Open reading frame sso2387 from the archaeon Sulfolobus solfataricus encodes a polypeptide with protein-serine kinase activityRho-kinase mediates diphosphorylation of myosin regulatory light chain in cultured uterine, but not vascular smooth muscle cells.Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase.Protein kinase inhibitors: contributions from structure to clinical compounds.Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.Investigation of the inhibitory effects of HA-1077 and Y-32885 on the translocation of PKCbetaI, PKCbetaII and PKCzeta in human neutrophils.A versatile synthesis of substituted isoquinolines.Research advances in kinase enzymes and inhibitors for cardiovascular disease treatment.Pigment Translocation in Caridean Shrimp Chromatophores: Receptor Type, Signal Transduction, Second Messengers, and Cross Talk Among Multiple Signaling Cascades.Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46.
P2860
Q24291677-878AD8D5-9424-4C36-A905-ECDDF03C8212Q26864028-2475C1E3-41A1-421A-9ED8-23925A741F24Q27671230-66F29AA5-D9AB-46D4-9E28-6F4599B961A4Q27702495-87B684FE-F337-450F-BEEB-38C05616F087Q28469309-58914AEC-1BE0-4788-9182-163657DAB801Q28478511-EE96B77D-9BC1-4519-9C7D-78886169F445Q33653633-99DFDD51-D4B8-46AD-8D8B-3E8EE09BC393Q33828265-C2DD26D3-DD02-47A1-A3AD-B1B748A1357CQ34402810-1AD83D62-620C-4F79-BCA2-3F8020C4F048Q34674191-6A047713-64A6-4207-A660-E441CA05EDC0Q35006231-B2D0DC03-AD44-4BB0-A974-008EDDEDAF7CQ35370325-0E4FDEA4-4AC9-4918-8749-CC5CD4D693D7Q36171342-0A15A64E-165B-42A8-A6E9-FC0499ED09ACQ37417742-97D04D85-C923-4217-B026-05E61F6B1E86Q37769931-11C7E47B-ECA5-4AAF-B0C2-7AB5DD82D768Q38166201-0DE7FC05-8441-412D-A62D-99DAD16082CCQ38584194-C54E8EFA-F331-4FFA-B63D-D6CFC54E00C5Q42289012-5AF274A1-BFA5-419D-8D6E-618B7939986FQ42397178-FB9A3CE7-537D-44D2-A436-DA9FBB206905Q47121794-CE85095F-CAA2-49E8-8773-390768CD63E4Q50221705-46827C29-4E5D-47B9-BDA8-9A7F989E05C1Q54978909-9B4A6E83-9AFB-4645-9020-05D59F7009E5
P2860
H-series protein kinase inhibitors and potential clinical applications.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
H-series protein kinase inhibitors and potential clinical applications.
@ast
H-series protein kinase inhibitors and potential clinical applications.
@en
type
label
H-series protein kinase inhibitors and potential clinical applications.
@ast
H-series protein kinase inhibitors and potential clinical applications.
@en
prefLabel
H-series protein kinase inhibitors and potential clinical applications.
@ast
H-series protein kinase inhibitors and potential clinical applications.
@en
P2093
P1476
H-series protein kinase inhibitors and potential clinical applications.
@en
P2093
P304
P356
10.1016/S0163-7258(98)00070-9
P577
1999-05-01T00:00:00Z